SpringWorks Therapeutics, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Stamford CT United States (2017)

Organization Overview

First Clinical Trial
2019
NCT03905148
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

SpringWorks Therapeutics, Inc.